151 related articles for article (PubMed ID: 37375504)
1. CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9.
Ying M; Wang H; Liu T; Han Z; Lin K; Shi Q; Zheng N; Ye T; Gong H; Xu F
Pathogens; 2023 Jun; 12(6):. PubMed ID: 37375504
[TBL] [Abstract][Full Text] [Related]
2. Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons.
Chen Y; Zhi S; Liang P; Zheng Q; Liu M; Zhao Q; Ren J; Cui J; Huang J; Liu Y; Songyang Z
Mol Ther Methods Clin Dev; 2020 Sep; 18():33-43. PubMed ID: 32577430
[TBL] [Abstract][Full Text] [Related]
3. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
[TBL] [Abstract][Full Text] [Related]
4. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
[TBL] [Abstract][Full Text] [Related]
5. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
Zhang I; Hsiao Z; Liu F
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
[TBL] [Abstract][Full Text] [Related]
6. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HSV-1 Replication by Gene Editing Strategy.
Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
9. Developing oncolytic
Ebrahimi S; Makvandi M; Abbasi S; Azadmanesh K; Teimoori A
Iran J Basic Med Sci; 2020 Jul; 23(7):937-944. PubMed ID: 32774817
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
11. Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing.
Huang X; Li X; Yang L; Wang P; Yan J; Nie Z; Gao Y; Li Z; Wen J; Cao X
Curr Gene Ther; 2022; 22(1):66-77. PubMed ID: 34148538
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of herpes simplex virus infections: past, present, and future.
Whitley R; Baines J
F1000Res; 2018; 7():. PubMed ID: 30443341
[TBL] [Abstract][Full Text] [Related]
14. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.
Wu N; Watkins SC; Schaffer PA; DeLuca NA
J Virol; 1996 Sep; 70(9):6358-69. PubMed ID: 8709264
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27.
Zhu Z; Schaffer PA
J Virol; 1995 Jan; 69(1):49-59. PubMed ID: 7983745
[TBL] [Abstract][Full Text] [Related]
16. The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0.
Sekulovich RE; Leary K; Sandri-Goldin RM
J Virol; 1988 Dec; 62(12):4510-22. PubMed ID: 2846867
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2.
Duan Q; Liu T; Yuan P; Huang C; Shao Q; Xu L; Sun J; Huang G; Chen Z
J Ethnopharmacol; 2020 Mar; 249():112405. PubMed ID: 31743766
[TBL] [Abstract][Full Text] [Related]
18. Targeted Promoter Replacement Reveals That Herpes Simplex Virus Type-1 and 2 Specific VP16 Promoters Direct Distinct Rates of Entry Into the Lytic Program in Sensory Neurons
Thompson RL; Sawtell NM
Front Microbiol; 2019; 10():1624. PubMed ID: 31396171
[TBL] [Abstract][Full Text] [Related]
19. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
[TBL] [Abstract][Full Text] [Related]
20. Screening Method for CRISPR/Cas9 Inhibition of a Human DNA Virus: Herpes Simplex Virus.
Neuhausser WM; Oh HS; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Bio Protoc; 2020 Sep; 10(17):e3748. PubMed ID: 33659408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
